investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
Carol Thiele
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Estela Jacinto
The Regulation of Cell Metabolism and Proliferation by mTOR complex 2
All cancers but non-melanoma skin cancer
Xiao-Tong Song
Cancer and Stroma-Targeted Immunotherapy with a Gentically Modified DC Vaccine
All cancers but non-melanoma skin cancer
Howard Young
Consequences of Chronic Interferon-Gamma Expression on the Host
All cancers but non-melanoma skin cancer
Anne Goldfeld
Checkpoints of TNF Gene Regulation
All cancers but non-melanoma skin cancer
Matthew L Freedman
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
All cancers but non-melanoma skin cancer
Chantal Guillemette
Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)
All cancers but non-melanoma skin cancer
Denis C Guttridge
Second Cancer Cachexia Conference: Evolving Mechanisms and Therapies
All cancers but non-melanoma skin cancer
Deborah Johnson
Maf1, a novel negative transcriptional regulator of the TATA binding protein
All cancers but non-melanoma skin cancer
James Dennis
Metabolic reprogramming in cancer cells and the hexosamine biosynthesis pathway
All cancers but non-melanoma skin cancer
